rs11228583 - SMIM38 - MYEOV

Magnitude 2.8 · 1 study on file

Reported associations

  • Genome-Wide Association Scan for Variants Associated with Early-Onset Prostate Cancer - Unknown journal (n.d.) · Unknown authors · PubMed 24740154

    ABSTRACT: Prostate cancer is the most common non-skin cancer and the second leading cause of cancer related mortality for men in the United States. There is strong empirical and epidemiological evidence supporting a stronger role of genetics in early-onset prostate cancer. We performed a genome-wide association scan for early-onset prostate cancer. Novel aspects of this study include the focus on early-onset disease (defined as men with prostate cancer diagnosed before age 56 years) and use of publically available control genotype data from previous genome-wide association studies. We found genome-wide significant (p<5×10−8) evidence for variants at 8q24 and 11p15 and strong supportive evidence for a number of previously reported loci. We found little evidence for individual or systemat


Auto-generated from study metadata. AI-synthesised commentary is added when this entry is regenerated through content-service's LLM mode.

Lifestyle context

Concrete actions anchored to the cited research. We do not prescribe, we describe.

Screening

  • early prostate cancer screening strategy Moderate

    T allele carriers have 1.33-fold increased risk for prostate cancer diagnosed before age 56

    discuss screening timeline and frequency with physician